Work

Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate Cancer

Year: 2003

Type: article

Study design: Clinical Trial

Source: Human Gene Therapy

DOI: 10.1089/10430340360535788

Authors: Hiroyuki Kubo, Thomas A. Gardner, Yoshitaka Wada, Kenneth S. Koeneman, Akinobu Gotoh, Ling Yang, Chinghai Kao, So Dug Lim, Mahul B. Amin, Hua Yang, Margaret E. Black, Shigeji Matsubara, Masayuki Nakagawa, Jay Y. Gillenwater, Haiyen E. Zhau, Leland W.K. Chung

Institutions: Emory University, University of Virginia Health System, Winship Cancer Institute, University of Virginia, Kobe University, Indiana University, Washington State University, Kagoshima University

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: University of Virginia, National Institutes of Health, National Cancer Institute

Awards: LOCOREGIONAL GENE THERAPY FOR CANCER METASTASES, G1881610144, G4199401577, AD OC TK/VAL GENE THERAPY CLINICAL CORRELATES

OpenAlex ID: W2013619396

FWCI: 8.984

Cites: 49

Cited by: 127

Related to: 10